A. Oštrbenk

发表

Intra‐ and inter‐laboratory agreement of the FAM19A4/mir124‐2 methylation test: Results from an international study

M. Poljak, A. Floore, S. de Sanjosé, 2019, Journal of clinical laboratory analysis.

Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.

M. Poljak, K. Seme, A. Šterbenc, 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Evaluation of the Clinical Performance of the HPV-Risk Assay Using the VALGENT-3 Panel

M. Poljak, P. Snijders, M. Arbyn, 2017, Journal of Clinical Microbiology.

Pre‐vaccination prevalence of infections with 25 non‐high‐risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening

M. Poljak, I. Klavs, V. Učakar, 2014, Journal of medical virology.

Validation of EUROArray HPV test using the VALGENT framework.

M. Poljak, S. Garland, M. Arbyn, 2018, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Commercially available molecular tests for human papillomaviruses (HPV): 2015 update.

M. Poljak, K. Seme, A. Oštrbenk, 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

HIGH-RISK HUMAN PAPILLOMAVIRUS ( HPV ) INFECTION IN WOMEN UNDERGOING IN VITRO FERTILIZATION

M. Poljak, A. Oštrbenk, E. Bokal, 2013 .

High-Risk Human Papillomavirus (Hpv) Infection in Women Undergoing in Vitro Fertilization / Okužbe Z Visokorizičnimi Genotipi Humanih Papilomskih Virusov (Hpv) Pri Ženskah, Vključenih V Postopke Zunajtelesne Oploditve

M. Poljak, E. Vrtacnik Bokal, A. Oštrbenk, 2013 .

The Abbott RealTime High Risk HPV test is a clinically validated human papillomavirus assay for triage in the referral population and use in primary cervical cancer screening in women 30 years and older: a review of validation studies.

M. Poljak, A. Oštrbenk, Anja Oštrbenk, 2013, Acta dermatovenerologica Alpina, Pannonica, et Adriatica.

Comparison of Clinical and Analytical Performance of the Abbott RealTime High Risk HPV Test to the Performance of Hybrid Capture 2 in Population-Based Cervical Cancer Screening

M. Poljak, K. Seme, P. Hillemanns, 2011, Journal of Clinical Microbiology.

Citation analysis of Acta Dermatovenerologica Alpina, Pannonica et Adriatica: 1992-2013.

M. Poljak, A. Oštrbenk, 2015, Acta dermatovenerologica Alpina, Pannonica, et Adriatica.

Citation analysis of Acta Dermatovenerologica Alpina, Pannonica et Adriatica: 1992-2011.

M. Poljak, A. Oštrbenk, Mateja Škamperle, 2012, Acta dermatovenerologica Alpina, Pannonica, et Adriatica.

Citation analysis of Acta Dermatovenerologica Alpina, Pannonica et Adriatica 1992-2008.

M. Poljak, A. Oštrbenk, 2009, Acta dermatovenerologica Alpina, Pannonica, et Adriatica.

FAM19A4/miR124‐2 methylation in invasive cervical cancer: A retrospective cross‐sectional worldwide study

M. Poljak, A. Floore, S. de Sanjosé, 2019, International journal of cancer.

DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort

M. Poljak, E. Schuuring, A. V. D. Van Der Zee, 2018, International journal of cancer.

Clinical Evaluation of INNO-LiPA HPV Genotyping EXTRA II Assay Using the VALGENT Framework

M. Poljak, M. Arbyn, A. Oštrbenk, 2018, International journal of molecular sciences.

Seroprevalences of Antibodies to 11 Human Papillomavirus (HPV) Types Mark Cumulative HPV Exposure

M. Poljak, J. Dillner, Helena Faust, 2018, The Journal of infectious diseases.

Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework

M. Poljak, M. Arbyn, A. Oštrbenk, 2018, Journal of Clinical Microbiology.

Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT framework.

M. Poljak, M. Arbyn, A. Oštrbenk, 2018, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Molecular characterization, tissue tropism, and genetic variability of the novel Mupapillomavirus type HPV204 and phylogenetically related types HPV1 and HPV63

M. Poljak, K. Seme, A. Šterbenc, 2017, PloS one.

Effect of naturally acquired type-specific serum antibodies against human papillomavirus type 16 infection.

M. Poljak, J. Dillner, K. Elfström, 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Global Genomic Diversity of Human Papillomavirus 11 Based on 433 Isolates and 78 Complete Genome Sequences

M. Poljak, K. Seme, S. Garland, 2014, Journal of Virology.

Global Genomic Diversity of Human Papillomavirus 6 Based on 724 Isolates and 190 Complete Genome Sequences

M. Poljak, K. Seme, S. Garland, 2014, Journal of Virology.

190 Complete Genome Sequences and Papillomavirus 6 Based on 724 Isolates Global Genomic Diversity of Human

K. Seme, A. Fiander, E. Franco, 2014 .

Identification of a Novel Human Papillomavirus, Type HPV199, Isolated from a Nasopharynx and Anal Canal, and Complete Genomic Characterization of Papillomavirus Species Gamma-12

M. Poljak, A. Šterbenc, Jingjing Li, 2015, PloS one.

Specificity of the Linear Array HPV Genotyping Test for detecting human papillomavirus genotype 52 (HPV-52).

M. Poljak, A. Oštrbenk, B. Kocjan, 2014, Acta dermatovenerologica Alpina, Pannonica, et Adriatica.